Company profile: QuanDx
1.1 - Company Overview
Company description
- Provider of life science reagents and molecular diagnostic kits, including the Q-Fusion multiplex system and Q30 screening kit for leukemia fusion genes, Yin-Yang Probes for affordable, multiplexed tests for various diseases, and a High Risk HPV Genotyping Assay detecting 14 types of high-risk HPV with automatic result interpretation in a single tube reaction.
Products and services
- Yin-Yang Probes: Proprietary technology producing affordable, multiplexed tests for various diseases, enabling multiplexed diagnostics across diverse disease applications with cost-efficiency
- High Risk HPV Genotyping Assay: Single-tube assay detects 14 types of high-risk HPV and offers automatic result interpretation, consolidating genotyping within one reaction
- Q-Fusion: Multiplex system delivering rapid, cost-effective testing of leukemia fusion genes, built to evaluate multiple gene fusions associated with leukemia
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to QuanDx
Mitotyping Technologies
HQ: United States
Website
- Description: Provider of forensic DNA analysis services for the criminal justice system, forensic laboratories, and anthropological applications, including mitochondrial DNA testing from small samples such as 2mm hair fragments or single teeth.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mitotyping Technologies company profile →
Embark Veterinary
HQ: United States
Website
- Description: Provider of dog DNA testing to end preventable diseases in dogs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Embark Veterinary company profile →
Caris Life Sciences
HQ: United States
Website
- Description: Provider of molecular profiling and AI-driven precision oncology solutions, offering tissue-based profiling, specimen testing services to identify molecular cancer characteristics for personalized treatment, shipper kits for specimen transport, and billing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caris Life Sciences company profile →
Feldan Therapeutics
HQ: Canada
Website
- Description: Provider of a patented peptide-based technology platform for delivering therapeutic compounds into cells, including the Feldan Shuttle, and FLD-103, an intralesional treatment for basal cell carcinoma that targets BCC cells by disrupting an intracellular component involved in the disease’s pathophysiology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Feldan Therapeutics company profile →
Precision Biomonitoring
HQ: Canada
Website
- Description: Provider of biotechnology and research specializing in various types of DNA and testing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precision Biomonitoring company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for QuanDx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to QuanDx
2.2 - Growth funds investing in similar companies to QuanDx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for QuanDx
4.2 - Public trading comparable groups for QuanDx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →